HYPERPHOSPHATEMIA PATIENTS ON HEMODIALYSIS

Clinical trials for HYPERPHOSPHATEMIA PATIENTS ON HEMODIALYSIS explained in plain language.

Never miss a new study

Get alerted when new HYPERPHOSPHATEMIA PATIENTS ON HEMODIALYSIS trials appear

Sign up with your email to follow new studies for HYPERPHOSPHATEMIA PATIENTS ON HEMODIALYSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Completed 1

New hope for dialysis patients battling dangerous mineral buildup

Disease control Completed

This study tested a new drug called TS-172 to see if it could safely lower high phosphorus levels in people on kidney dialysis. High phosphorus is a common and serious problem for dialysis patients. Researchers compared the drug to a placebo (a dummy pill) in 101 patients to see …

Matched conditions: HYPERPHOSPHATEMIA PATIENTS ON HEMODIALYSIS

Phase: PHASE3 • Sponsor: Taisho Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Apr 21, 2026 12:43 UTC

HYPERPHOSPHATEMIA PATIENTS ON HEMODIALYSIS

Get alerted when new HYPERPHOSPHATEMIA PATIENTS ON HEMODIALYSIS trials appear

New hope for dialysis patients battling dangerous mineral buildup